These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26972660)

  • 1. In Regard to Lewis et al.
    Fiorino C; Cozzarini C
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):859-60. PubMed ID: 26972660
    [No Abstract]   [Full Text] [Related]  

  • 2. In Reply to Fiorino and Cozzarini.
    Lewis SL; Patel PR; Palta M; Yoo DS; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):860-1. PubMed ID: 26972661
    [No Abstract]   [Full Text] [Related]  

  • 3. Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.
    von Eyben FE; Kiljunen T; Kangasmaki A; Kairemo K; von Eyben R; Joensuu T
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):466-7. PubMed ID: 26383684
    [No Abstract]   [Full Text] [Related]  

  • 4. In Reply to von Eyben et al.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):467-8. PubMed ID: 26383685
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer.
    Lieng H; Pintilie M; Bayley A; Berlin A; Bristow R; Chung P; Gospodarowicz M; Huang R; Ménard C; Warde P; Catton C
    Radiother Oncol; 2017 Jan; 122(1):93-98. PubMed ID: 27838147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
    Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionation for prostate cancer and PROs.
    Bolla M
    Lancet Oncol; 2015 Dec; 16(16):1570-1. PubMed ID: 26522335
    [No Abstract]   [Full Text] [Related]  

  • 8. Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study.
    Di Muzio NG; Fodor A; Noris Chiorda B; Broggi S; Mangili P; Valdagni R; Dell'Oca I; Pasetti M; Deantoni CL; Chiara A; Berardi G; Briganti A; Calandrino R; Cozzarini C; Fiorino C
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):490-500. PubMed ID: 26961088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.
    Fersino S; Tebano U; Mazzola R; Giaj-Levra N; Ricchetti F; Di Paola G; Fiorentino A; Sicignano G; Naccarato S; Ruggieri R; Cavalleri S; Alongi F
    Clin Genitourin Cancer; 2017 Aug; 15(4):e667-e673. PubMed ID: 28237181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
    Kaidar-Person O; Roach M; Créhange G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-pelvic radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward. In regard to Kaidar-Person et al.
    Yassa M; Vavassis P; Niazi T
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):634-5. PubMed ID: 24138911
    [No Abstract]   [Full Text] [Related]  

  • 13. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator™ micro-MLC: A dosimetric analysis.
    Carosi A; Ingrosso G; Ponti E; Lancia A; Santoni R
    Acta Oncol; 2016; 55(1):116-21. PubMed ID: 26057536
    [No Abstract]   [Full Text] [Related]  

  • 15. In regard to Dyk et al.
    Gill BS; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):881-2. PubMed ID: 25752409
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI-guided radiotherapy results in fewer toxicities for localized prostate cancer.
    Nierengarten MB
    Cancer; 2023 May; 129(9):1303-1304. PubMed ID: 37029507
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer: Hypofractionated radiotherapy confirmed effective and safe.
    Thoma C
    Nat Rev Urol; 2016 Aug; 13(8):435. PubMed ID: 27377157
    [No Abstract]   [Full Text] [Related]  

  • 18. Image-guided Intensity-modulated Radiotherapy for Prostate Cancer Employing Hypofractionation and Simultaneous Integrated Boost: Results of a Consecutive Case Series with Focus on Erectile Function.
    Girelli G; Franco P; Sciacero P; Cante D; Borca VC; Pasquino M; Annoscia S; Tofani S; La Porta MR; Ricardi U
    Anticancer Res; 2015 Jul; 35(7):4177-82. PubMed ID: 26124375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
    Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMRT with capecitabine in advanced pancreatic cancer. In regard to Passoni et al.
    Ren G; Xia T; Wang Y
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):431. PubMed ID: 24837893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.